FDA announces recall of Ga. compounder's sterile products

03/22/2013 | Reuters

Clinical Specialties Compounding recalled all the sterile products it has distributed in the country since Oct. 19, and the FDA warned health care providers following reports of serious eye infections tied to injections of the cancer treatment Avastin that had been prepared by the Georgia pharmacy. The FDA said the recall was extended to all of the company's other sterile products due to concerns about a lack of sterility assurance and covers dozens of treatments, including many eye treatments and antibiotics.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY